S
Sophie Susen
Researcher at Pasteur Institute
Publications - 200
Citations - 7139
Sophie Susen is an academic researcher from Pasteur Institute. The author has contributed to research in topics: Von Willebrand factor & Medicine. The author has an hindex of 35, co-authored 173 publications receiving 5597 citations. Previous affiliations of Sophie Susen include university of lille & Lille University of Science and Technology.
Papers
More filters
Journal ArticleDOI
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence.
Julien Poissy,Julien Goutay,Morgan Caplan,Erika Parmentier,Thibault Duburcq,Fanny Lassalle,Emmanuelle Jeanpierre,Antoine Rauch,Julien Labreuche,Sophie Susen +9 more
Journal ArticleDOI
Acquired von Willebrand syndrome in aortic stenosis.
André Vincentelli,Sophie Susen,Thierry Le Tourneau,Isabelle Six,Olivier Fabre,Francis Juthier,Anne Bauters,Christophe Decoene,Jenny Goudemand,Alain Prat,Brigitte Jude +10 more
TL;DR: Von Willebrand factor abnormalities are directly related to the severity of aortic stenosis and are improved by valve replacement in the absence of mismatch between patient and prosthesis.
Journal ArticleDOI
Acquired von Willebrand Syndrome After Continuous-Flow Mechanical Device Support Contributes to a High Prevalence of Bleeding During Long-Term Support and at the Time of Transplantation
Nir Uriel,Sang Woo Pak,Ulrich P. Jorde,Brigitte Jude,Sophie Susen,André Vincentelli,Pierre Vladimir Ennezat,Sarah Cappleman,Yoshifumi Naka,Donna Mancini +9 more
TL;DR: Patients with the HM II had a high incidence of bleeding events during device support and at heart transplantation, and all HM II patients had reduced high molecular weight von Willebrand factor multimers.
Journal ArticleDOI
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
Gilles Pernod,P. Albaladejo,Anne Godier,Charles Marc Samama,Sophie Susen,Yves Gruel,Normand Blais,Pierre Fontana,Ariel Cohen,Juan V. Llau,Nadia Rosencher,Jean-François Schved,Emmanuel de Maistre,Meyer Michel Samama,Patrick Mismetti,Pierre Sié +15 more
TL;DR: For urgent surgery with haemorrhagic risk, the drug plasma concentration should be less or equal to 30ng/mL for dabigatran and rivaroxaban and the administration of a procoagulant drug is discussed according to the NOAC concentration and the possibilities of mechanical haemostasis.
Journal ArticleDOI
High-dose tranexamic acid reduces blood loss in postpartum haemorrhage
Anne-Sophie Ducloy-Bouthors,Brigitte Jude,Alain Duhamel,F. Broisin,Cyril Huissoud,Hawa Keita-Meyer,Laurent Mandelbrot,Nadia Tillouche,Sylvie Fontaine,Françoise Le Goueff,Sandrine Depret-Mosser,Benoit Vallet,Sophie Susen +12 more
TL;DR: This study is the first to demonstrate that high-dose TA can reduce blood loss and maternal morbidity in women with PPH and the observed side effects were mild and transient.